RARA CRAFT DATABASE for FDA Medical Devices
510(k)K222117

FDA DEVICE FACTS

Swang-Ganz IQ pulmonary artery catheter

Edwards Lifesiences, LLC

FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。

DECISION DATEDecember 9, 2022PRODUCT CODEDYG

Indications for use

The primary indications for the Swan-Ganz IQ Pulmonary Arterial catheter includes:

• Acute heart failure

• Severe hypovolemia

• Complex circulatory situations

• Medical emergencies

• Adult respiratory distress syndrome

• Gram negative sepsis

• Drug intoxication

• Acute renal failure

• Hemorrhagic pancreatitis

• Intra and post-operative management of high risk patients

• History of pulmonary or cardiac disease

• Fluid shifts ( e.g., extensive intra-abdominal operations)

• Management of high-risk obstetrical patients

• Diagnosed cardiac disease

• Toxemia

• Premature separation of placenta

• Cardiac output determinations

• Differential diagnosis of mitral regurgitation and ventricular septal rupture

• Diagnosis of cardiac tamponade Secondary indications include the following:

• Blood Sampling

• Infusion of saline and dextrose solutions

See the full product information製品情報をすべて見るには

Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。

Start free 7-day access7日間無料で利用するLog inログイン

OFFICIAL FDA SOURCES

FDA Record and Public Document Status

Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。

Information reviewed:情報の確認日: August 22, 2026